cd16323518a662b9…

{
  "id": "NCT00007189",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this trial is to test the ability of the non-steroidal anti-inflammatory medications naproxen and celecoxib to delay or prevent the onset of AD and age-related cognitive decline.",
    "completionDate": null,
    "conditions": [
      "Alzheimer Disease"
    ],
    "enrollmentCount": 2625,
    "enrollmentType": null,
    "nctId": "NCT00007189",
    "phase": "PHASE3",
    "sponsorId": "seattle-institute-for-biomedical-and-clinical-research",
    "startDate": "2001-01",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)",
    "url": "https://clinicaltrials.gov/study/NCT00007189"
  }
}